Steven Favaloro
Chief Executive Officer bij Genezen Laboratories, Inc.
Profiel
Steve, who joined Ampersand as an Executive Advisor in 2022, is a passionate life sciences investor and entrepreneur.
He is currently President and CEO of Ampersand portfolio company Genezen, a leading viral vector CDMO.
Prior, Steve was CFO at Arbor Biotechnologies, a next generation gene editing therapeutic company.
Steve also served as CFO at Ampersand portfolio company Arranta Bio, a leading CDMO for mRNA, from its founding in 2019 to its sale to Recipharm in February 2022.
Prior to this, Steve was CFO at Ampersand portfolio company Brammer Bio, where he oversaw a period of rapid expansion and capital deployment from 2016 to 2019, growing the company from 80 employees to over 650 at the time of its sale to Thermo Fisher Scientific in May 2019.
Prior to joining Brammer, Steve had finance roles of increasing responsibility at Millipore, Merck KGaA, and Bruker Corporation.
He received his M.B.A.
and M.S.
from the Carroll School of Management at Boston College and a B.A.
in Economics from Boston College.
Actieve functies van Steven Favaloro
| Bedrijven | Functie | Begin |
|---|---|---|
Genezen Laboratories, Inc.
 Genezen Laboratories, Inc. BiotechnologyHealth Technology Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023. | Chief Executive Officer | 13-03-2023 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Consultant / Advisor | 01-03-2023 |
Eerdere bekende functies van Steven Favaloro
| Bedrijven | Functie | Einde |
|---|---|---|
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01-03-2023 |
Arranta Bio Holdings LLC
 Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Director of Finance/CFO | 01-02-2022 |
Brammer Bio LLC
 Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01-09-2019 |
Opleiding van Steven Favaloro
| Boston College | Undergraduate Degree |
| Wallace E Carroll School of Management | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Health Technology |
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023. | Health Technology |
